ورود به حساب

نام کاربری گذرواژه

گذرواژه را فراموش کردید؟ کلیک کنید

حساب کاربری ندارید؟ ساخت حساب

ساخت حساب کاربری

نام نام کاربری ایمیل شماره موبایل گذرواژه

برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید


09117307688
09117179751

در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید

دسترسی نامحدود

برای کاربرانی که ثبت نام کرده اند

ضمانت بازگشت وجه

درصورت عدم همخوانی توضیحات با کتاب

پشتیبانی

از ساعت 7 صبح تا 10 شب

دانلود کتاب Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook

دانلود کتاب تصویربرداری عصبی پزشکی هسته ای بالینی: کتاب موردی آموزشی

Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook

مشخصات کتاب

Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook

ویرایش:  
نویسندگان:   
سری:  
ISBN (شابک) : 3030408922, 9783030408923 
ناشر: Springer 
سال نشر: 2020 
تعداد صفحات: 394 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 36 مگابایت 

قیمت کتاب (تومان) : 55,000



ثبت امتیاز به این کتاب

میانگین امتیاز به این کتاب :
       تعداد امتیاز دهندگان : 3


در صورت تبدیل فایل کتاب Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب تصویربرداری عصبی پزشکی هسته ای بالینی: کتاب موردی آموزشی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.


توضیحاتی در مورد کتاب تصویربرداری عصبی پزشکی هسته ای بالینی: کتاب موردی آموزشی

این کتاب به عنوان کتاب موردی برای تصویربرداری عصبی پزشکی هسته ای بالینی عمل می کند. تفسیر بالینی مطالعات تصویربرداری عصبی پزشکی هسته ای اغلب چالش برانگیز است، عمدتاً به دلیل پیچیدگی نوروآناتومی و فقدان کتاب های مرجع حمایتی. این یک نیاز برآورده نشده در بسیاری از بیمارستان های آموزشی است. این کتاب درسی با استفاده از یک رویکرد عملی و مبتنی بر مورد، خوانندگان را از طریق تصویربرداری عصبی پزشکی هسته‌ای بالینی از بیماری‌ها و شرایط عمده عصبی، از جمله زوال عقل، صرع، و مرگ مغزی راهنمایی می‌کند. در اینجا دستورالعمل‌ها و تکنیک‌های اساسی برای شیوه‌های تصویربرداری عصبی پزشکی هسته‌ای گنجانده شده است، که در کنار نمونه‌های موردی که شامل نمایش تصویربرداری استاندارد و تفسیر دقیق است، تنظیم شده است. هر فصل با نمونه هایی از تصویربرداری طبیعی مغز به عنوان نقطه مرجع برای بقیه فصل آغاز می شود، که سپس نمونه های موردی مفصلی از این بیماری ها را از طریق تکنیک های مختلف تصویربرداری ارائه می دهد. هر یک از موارد، یافته های کلیدی بالینی و تصویربرداری و برداشت های دقیق را برجسته می کند. این یک راهنمای ایده آل برای دستیاران، همکارها و حتی پزشکان متخصص پزشکی هسته ای به عنوان مرجع و ابزار آموزشی برای تصویربرداری عصبی در پزشکی هسته ای بالینی است. برای رزیدنت‌ها، کارآموزان و پزشکان جوان در آماده‌سازی برای آزمایش‌های ضمن خدمت و معاینات هیئت مدیره ارزش قابل توجهی خواهد داشت.

توضیحاتی درمورد کتاب به خارجی

This book serves as a casebook for clinical nuclear medicine neuroimaging. Clinical interpretation of nuclear medicine neuroimaging studies is often challenging, mainly due to the complexity of neuroanatomy and a lack of supportive reference books. This is an unmet need in many teaching hospitals. Utilizing a hands-on, case-based approach, this textbook guides readers through clinical nuclear medicine neuroimaging of major neurological diseases and conditions, including dementia, epilepsy, and brain death. Included here are basic guidelines and techniques for nuclear medicine neuroimaging practices, set alongside case examples that include standardized imaging display and detailed interpretation. Each chapter begins with examples of normal brain imaging as a reference point for the remainder of the chapter, which then presents detailed case examples of these diseases through various imaging techniques. Each of the cases highlights clinical and imaging key findings and precise impressions. This is an ideal guide for residents, fellows, and even practicing nuclear medicine physicians as a reference and teaching tool for neuroimaging in clinical nuclear medicine. It will be of significant value to residents, trainees, and young physicians in preparation for their in-service tests and board examinations.


فهرست مطالب

Preface
Acknowledgments
Contents
1: Positron Emission Tomography (PET) in Dementias
	Case 1.1 Probable Normal Brain FDG PET Study
		Clinical Information
		FDG PET Findings (Fig. 1.1)
		Discussion and Follow-Up
		Case Summary
	Case 1.2 Probable Normal Aging
		Clinical Information
		FDG PET Findings (Fig. 1.2)
		Discussion and Follow-Up
		Case Summary
	Case 1.3 Probable Mild Cognitive Impairment (MCI)
		Clinical Information
		FDG PET Findings (Fig. 1.3)
		Discussion and Follow-Up
		Case Summary
	Case 1.4 Probable Early-Onset Alzheimer’s Disease (EOAD)
		Clinical Information
		FDG PET Findings (Fig. 1.4)
		Discussion
		Case Summary
	Case 1.5 Probable Late-Onset Alzheimer’s Disease (LOAD)
		Clinical Information
		FDG PET Findings (Fig. 1.5)
		Discussion and Follow-Up
		Case Summary
	Case 1.6 Probable Frontotemporal Dementia (FTD)
		Clinical Information
		FDG PET Findings (Fig. 1.6)
		Discussion
		Case Summary
	Case 1.7 Probable Behavioral Variant FTD (bvFTD)
		Clinical Information
		FDG PET Findings (Fig. 1.7)
		Discussion
		Case Summary
	Case 1.8 Probable Semantic Variant Primary Progressive Aphasia (svPPA)
		Clinical Information
		FDG PET Findings (Fig. 1.8)
		Discussion
		Case Summary
	Case 1.9 Probable Corticobasal Degeneration (CBD)
		Clinical Information
		FDG PET Findings (Fig. 1.9)
		Discussion and Follow-Up
		Case Summary
	Case 1.10 Probable Dementia with Lewy Bodies (DLB)
		Clinical Information
		FDG PET Findings (Fig. 1.10)
		Discussion
		Case Summary
	Case 1.11 Probable AD with Vascular Pathology
		Clinical Information
		FDG PET Findings (Fig. 1.11)
		Discussion
		Case Summary
	Case 1.12 Dementia Resulting from Traumatic Brain Injury (TBI)
		Clinical Information
		FDG PET Findings (Fig. 1.12)
		Discussion
		Case Summary
	Case 1.13 Probable Vascular Dementia (VD)
		Clinical Information
		FDG PET Findings (Fig. 1.13)
		Discussion and Follow-Up
		Case Summary
	Case 1.14 Possible Mixed Dementia (AD with DLB Pathology)
		Clinical Information
		FDG PET Findings (Fig. 1.14)
		Discussion and Follow-Up
		Case Summary
	Case 1.15 Possible Mixed Dementia (FTD with AD Pathology)
		Clinical Information
		FDG PET Findings (Fig. 1.15)
		Discussion and Follow-Up
		Case Summary
	Case 1.16 Dementia Resulting from Major Depressive Disorder (MDD)
		Clinical Information
		FDG PET Findings (Fig. 1.16)
		Discussion and Follow-Up
		Case Summary
	Case 1.17 Aphasia Resulting from Brain Arteriovenous Malformation (AVM)
		Clinical Information
		FDG PET Findings (Fig. 1.17)
		Discussion and Follow-Up
		Case Summary
	Case 1.18 Dementia and Aphasia Resulting from Primary CNS Lymphoma (PCNSL)
		Clinical Information
		FDG PET Findings (Fig. 1.18)
		Discussion and Follow-Up
		Case Summary
	Case 1.19 Dementia of Unknown Type
		Clinical Information
		FDG PET Findings (Fig. 1.19)
		Discussion and Follow-Up
		Case Summary
	Case 1.20 Negative Amyloid Brain PET Scan
		Clinical Information
		F-18 Vizamyl PET/CT Imaging Findings (Fig. 1.20)
		Discussion and Follow-Up
		Case Summary
	Case 1.21 Positive Amyloid Brain PET Scan
		Clinical Information
		F-18 Vizamyl PET Imaging Findings (Fig. 1.21)
		Discussion and Follow-Up
		Case Summary
	References
2: Single Photon Emission Computed Tomography (SPECT) in Dementias
	Case 2.1 Probable Normal Aging
		Clinical Information
		SPECT Imaging Findings (Fig. 2.1)
		Discussion and Follow-Up
		Case Summary
	Case 2.2 Possible MCI
		Clinical Information
		SPECT Findings
		Discussions
		Case Summary
	Case 2.3 Possible Late-Onset Alzheimer’s Disease (LOAD)
		Clinical Information
		SPECT Imaging Findings (Fig. 2.3)
		Discussion and Follow-Up
		Case Summary
	Case 2.4 Probable Early-Onset Alzheimer’s Disease (EOAD)
		Clinical Information
		SPECT Imaging Findings (Fig. 2.4)
		Discussion
		Case Summary
	Case 2.5 Probable Frontotemporal Dementia (FTD)
		Clinical Information
		SPECT Imaging Findings
		Discussion and Follow-Up
		Case Summary
	Case 2.6 Probable Behavioral Variant Frontotemporal Dementia (bvFTD)
		Clinical Information
		SPECT Imaging Findings
		Discussion and Follow-Up
		Case Summary
	Case 2.7 Probable Dementia with Lewy Bodies (DLB)
		Clinical Information
		SPECT Imaging Findings
		Discussion and Follow-Up
		Case Summary
	Case 2.8 Probable Primary Progressive Aphasia (PPA) with AD Pathology
		Clinical Information
		SPECT Imaging Findings
		Discussion and Follow-Up
		Case Summary
	Case 2.9 Possible Vascular Dementia (VD) with bvFTD Pathology
		Clinical Information
		SPECT Imaging Findings (Fig. 2.9)
		Discussion and Follow-Up
		Case Summary
	Case 2.10 Probable Posterior Cortical Atrophy (PCA)
		Clinical Information
		SPECT Imaging Findings
		Discussion and Follow-Up
		Case Summary
	References
3: F-18 Fluorodeoxyglucose Positron Emission Tomography (FDG PET) in Epilepsies
	Case 3.1 Negative FDG PET
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.1)
		Discussion and Follow-Up
		Case Summary
	Case 3.2 Surgically Proven Left Mesial Temporal Lobe Epilepsy (MTLE)
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.2)
		Discussion and Follow-Up
		Case Summary
	Case 3.3 Probable Right Lateral Temporal Lobe Epilepsy (LTLE)
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.3)
		Discussion and Follow-Up
		Case Summary
	Case 3.4 Right Hemispheric Epilepsy
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.4)
		Discussion and Follow-Up
		Case Summary
	Case 3.5 Probable Multifocal Epilepsy
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.5)
		Discussion
		Case Summary
	Case 3.6 Ictal FDG PET
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.6)
		Discussion and Follow-Up
		Case Summary
	Case 3.7 Surgically Proven Right Insular Lobe Epilepsy
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.7)
		Discussion and Follow-Up
		Case Summary
	Case 3.8 Probable Right Frontal Lobe Epilepsy
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.8)
		Discussion and Follow-Up
		Case Summary
	Case 3.9 Seizures Due to Left Temporal Astrocytoma
		Clinical Information
		FDG PET Imaging Findings
		Discussion and Follow-Up
		Case Summary
	Case 3.10 Seizures Resulting from Cerebral Cavernous Malformations (CCMs)
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.10)
		Discussion and Follow-Up
		Case Summary
	Case 3.11 Seizures Due to Tuberous Sclerosis (TS)
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.11)
		Discussion and Follow-Up
		Case Summary
	Case 3.12 Seizures Due to Intrauterine Stroke
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.12)
		Discussion and Follow-Up
		Case Summary
	Case 3.13 Recurrent Seizures After Hemispherectomy
		Clinical Information
		FDG PET Imaging Findings (Fig. 3.13)
		Discussion and Follow-Up
		Case Summary
	References
4: Single Photon Emission Computed Tomography (SPECT) in Epilepsies
	Case 4.1 Probable Right Lateral Temporal Lobe Epilepsy (LTLE)
		Clinical Information
		SPECT and SISCOM Findings
		Discussion and Follow-Up
		Case Summary
	Case 4.2 Probable Left Occipitoparietal Epilepsy
		Clinical Information
		SPECT Findings (Fig. 4.2)
		Discussion and Follow-Up
		Case Summary
	Case 4.3 Probable Left Temporal Lobe Epilepsy (TLE)
		Clinical Information
		SPECT Findings (Fig. 4.3)
		Discussion and Follow-Up
		Case Summary
	Case 4.4 Surgically Proven Right Parietal Lobe Epilepsy (PLE) Due to Focal Cortical Dysplasia (FCD)
		Clinical Information
		SPECT and SISCOM Findings
		Discussion and Follow-Up
		Case Summary
	Case 4.5 Surgically Proven Left Lateral Temporal Lobe Epilepsy (LTLE)
		Clinical Information
		SPECT and SISCOM Findings
		Discussion and Follow-Up
		Summary
	Case 4.6 Probable Left Insular Epilepsy
		Clinical Information
		SPECT and SISCOM Findings
		Discussion and Follow-Up
		Case Summary
	Case 4.7 Probable Left Frontal Lobe Epilepsy (FLE)
		Clinical Information
		SPECT and SISCOM Findings
		Discussion and Follow-Up
		Case Summary
	Case 4.8 Multifocal Epilepsy Secondary to Tuberous Sclerosis (TS)
		Clinical Information
		SPECT and SISCOM Findings
		Discussions and Follow-Up
		Case Summary
	References
5: FDG PET Imaging of Brain Tumors
	Case 5.1 Primary Glioblastoma Multiforme (GBM)
		Clinical Information
		FDG PET CT Findings (Fig. 5.1)
		Discussion and Follow-Up
		Case Summary
	Case 5.2 Recurrent Glioblastoma Multiforme (GBM)
		Clinical Information
		FDG PET CT Findings (Fig. 5.2)
		Discussions and Follow-Up
		Case Summary
	Case 5.3 Primary CNS Lymphoma (PCNSL)
		Clinical Information
		FDG PET CT Findings (Fig. 5.3)
		Discussions and Follow-Up
		Case Summary
	Case 5.4 Secondary CNS Lymphoma (SCNSL)
		Clinical Information
		FDG PET CT Findings (Fig. 5.4)
		Discussion and Follow-Up
		Case Summary
	Case 5.5 Left Temporal Ganglioglioma
		Clinical Information
		FDG PET Findings (Fig. 5.5)
		Discussions and Follow-Up
		Case Summary
	Case 5.6 Leptomeningeal Melanoma
		Clinical Information
		FDG PET CT Findings (Fig. 5.6)
		Discussion and Follow-Up
		Case Summary
	Case 5.7 Multifocal Brain Metastases of Lung Origin
		Clinical Information
		Imaging Findings (Fig. 5.7)
		Discussion and Follow-Up
		Case Summary
	Case 5.8 Recurrent Brain Metastasis of Breast Origin
		Clinical Information
		FDG PET CT Findings (Fig. 5.8)
		Discussion and Follow-Up
		Case Summary
	References
6: Dopamine Transporter Scan (DaTscan)
	Case 6.1 Probable Normal DaTscan Consistent with Essential Tremor (ET)
		Clitnical Information
		DaTscan Findings
		Discussion and Follow-Up
		Case Summary
	Case 6.2 Abnormal DaTscan Likely due to PD and Coexisting AVM
		Clinical Information
		DaTscan Findings (Fig. 6.2)
		Discussion and Follow-Up
		Case Summary
	Case 6.3 Abnormal DaTscan due to Left-sided Stroke
		Clinical Information
		DaTscan Findings (Fig. 6.3)
		Discussion and Follow-Up
		Case Summary
	Case 6.4 Abnormal DaTscan with Right Striatum Being More Affected Than the Left
		Clinical Information
		DaTscan Findings (Fig. 6.4)
		Discussion and Follow-Up
		Case Summary
	Case 6.5 Probable Normal DaTscan Consistent with Neuroleptic-Induced Parkinsonism
		Clinical Information
		DaTscan Findings (Fig. 6.5)
		Discussion
		Case Summary
	Case 6.6 Abnormal DaTscan with Left Striatum Being More Affected Than the Right
		Clinical Information
		DaTscan Findings (Fig. 6.6)
		Discussion and Follow-Up
		Case Summary
	Case 6.7 Probable Abnormal DaTscan Suspicious for Early-Stage PD
		Clinical Information
		DaTscan Findings (Fig. 6.7)
		Discussion and Follow-Up
		Case Summary
	Case 6.8 Abnormal DaTscan due to CVA and Likely Early Stage of PD
		Clinical Information
		DaTscan Findings (Fig. 6.8)
		Discussion and Follow-Up
		Case Summary
	Case 6.9 Abnormal DaTscan Likely due to Corticobasal Degeneration (CBD)
		Clinical Information
		DaTscan Findings
		Discussion and Follow-Up
		Case Summary
	Case 6.10 Abnormal DaTscan Consistent with Advanced PD
		Clinical Information
		DaTscan Findings (Fig. 6.10)
		Discussion and Follow-Up
		Case Summary
	Case 6.11 Abnormal DaTscan due to Progressive Supranuclear Palsy (PSP)
		Clinical Information
		Imaging Findings
		Discussion and Follow-Up
		Case Summary
	Case 6.12 Abnormal DaTscan due to Multiple System Atrophy (MSA)
		Clinical Information
		Imaging Findings
		Discussion and Follow-Up
		Case Summary
	References
7: Cerebrospinal Fluid (CSF) Scintigraphy
	CSF Imaging in Normal Pressure Hydrocephalus (NPH)
		Case 7.1 Normal CSF Scintigraphy
			Clinical Information
			Imaging Findings (Fig. 7.1)
			Discussion and Follow-Up
			Case Summary
		Case 7.2 Slow CSF Flow and Transient Ventricular Reflux Likely Secondary to Brain Atrophy
			Clinical Information
			Imaging Findings (Fig. 7.2)
			Discussion and Follow-Up
			Case Summary
		Case 7.3 Abnormal CSF Scintigraphy Likely due to Hydrocephalus Ex Vacuo
			Clinical Information
			Imaging Findings (Fig. 7.3)
			Discussion and Follow-Up
			Case Summary
		Case 7.4 Abnormal CSF Scintigraphy Consistent with NPH
			Clinical Information
			Imaging Findings (Fig. 7.4)
			Discussion and Follow-Up
			Case Summary
		Case 7.5 NPH with a Favorable and Sustained Response to VP Shunting
			Clinical Information
			Imaging Findings (Fig. 7.5)
			Discussion and Follow-Up
			Case Summary
	CSF Leak Imaging
		Case 7.6 Normal Study Without Scintigraphic Evidence of CSF Leak
			Clinical Information
			Imaging Findings (Fig. 7.6)
			Discussion and Follow-Up
			Case Summary
		Case 7.7 Normal Study Including SPECT CT of the Head/Neck Without Evidence of CSF Leak
			Clinical Information
			Imaging Findings (Fig. 7.7)
			Discussion and Follow-Up
			Case Summary
		Case 7.8 CSF Leaks from T6 to L3
			Clinical Information
			Imaging Findings (Fig. 7.8)
			Discussion and Follow-Up
			Case Summary
		Case 7.9 CSF Leak into Right Posterior Nasal Cavity
			Clinical Information
			Imaging Findings (Fig. 7.9)
			Discussion and Follow-Up
			Case Summary
		Case 7.10 Positive CSF Leak Imaging and Negative Follow-Up After Multiple Blood Patches
			Clinical Information
			Imaging Findings (Fig. 7.10)
			Discussion and Follow-Up
			Case Summary
	CSF Imaging in the Evaluation of Shunt Patency
		Case 7.11 Patent Lumboperitoneal (LP) Shunt
			Clinical Information
			Imaging Findings (Fig. 7.11)
			Discussion and Follow-Up
			Case Summary
		Case 7.12 Essentially Normal Ommaya Shunt Study
			Clinical Information
			Imaging Findings (Fig. 7.12)
			Discussion
			Case Summary
		Case 7.13 Patent Ommaya Shunt with Uneven CSF Flow/Distribution
			Clinical Information
			Imaging Findings (Fig. 7.13)
			Discussion and Follow-Up
			Case Summary
		Case 7.14 Patent Ventriculoperitoneal (VP) Shunt
			Clinical Information
			Imaging Findings (Fig. 7.14)
			Discussion
			Case Summary
		Case 7.15 Obstruction of the Proximal and Distal VP Shunt Catheters
			Clinical Information
			Imaging Findings (Fig. 7.15)
			Discussion and Follow-Up
			Case Summary
		Case 7.16 Obstruction of the Distal VP Shunt Catheter
			Clinical Information
			Imaging Findings (Fig. 7.16)
			Discussion and Follow-Up
			Case Summary
	References
8: Miscellaneous Clinical Nuclear Medicine Neuroimaging Studies
	Brain Death Scintigraphy
		Case 8.1 Positive Study Consistent with Brain Death
			Clinical Information
			Imaging Findings (Fig. 8.1)
			Discussion and Follow-Up
			Case Summary
		Case 8.2 Positive Brain Death Scintigraphy with a “Hot Nose Sign”
			Imaging Findings (Fig. 8.2)
			Discussion and Follow-Up
			Case Summary
	Brain Perfusion SPECT of Chronic Lyme Encephalopathy
		Case 8.3 Negative Study without Scintigraphic Evidence of Lyme Encephalopathy
			Imaging Findings (Fig. 8.3)
			Discussion and Follow-Up
			Case Summary
		Case 8.4 Abnormal Brain Perfusion Study Suspicious for Lyme Encephalopathy
			Imaging Findings (Fig. 8.4)
			Discussion and Follow-Up
			Case Summary
		Case 8.5 Positive Study for Chronic Lyme Encephalopathy with Improvement on Follow-Up Imaging
			Imaging Findings
			Discussion and Follow-Up
			Case Summary
		Case 8.6 Positive Study Consistent with Lyme Encephalopathy Without Interval Improvement on Follow-Up Imaging
			Clinical Information
			Imaging Findings
			Discussion and Follow-Up
			Case Summary
	Others
		Case 8.7 Brain Perfusion SPECT Study as Part of the Wada Test
			Imaging Findings (Fig. 8.7)
			Discussion and Follow-Up
			Case Summary
		Case 8.8 Intracerebral Steal Phenomenon (ISP) on Brain Perfusion SPECT with Diamox Challenge
			Imaging Findings
			Discussion and Follow-Up
			Case Summary
		Case 8.9 Brain FDG PET of Possible Mycoplasma Encephalitis
			Clinical Information
			Imaging Findings (Fig. 8.9)
			Discussion and Follow-Up
			Case Summary
	References
Appendix I: Self-Assessment Quiz
	Quiz #1
	Quiz #2
	Quiz #3
	Quiz #4
	Quiz #5
	Quiz #6
	Quiz #7
	Quiz #8
	Quiz #9
	Quiz #10
	Quiz #11
	Quiz #12
	Quiz #13
	Quiz #14
	Quiz #15
	Quiz #16
	Quiz #17
	Quiz #18
	Quiz #19
	Quiz #20
	Quiz #21
	Quiz #22
	Quiz #23
	Quiz #24
	Quiz #25
	Quiz #26
	Quiz #27
	Quiz #28
	Quiz #29
	Quiz #30
	Correct Answers and Critiques
Appendix II: Imaging Protocols
	FDG PET CT Brain Imaging
		Principle
		Indications in Our Clinic
		Radiopharmaceutical and Dosage
		Patient Preparation
		Procedure
	Amyoid PET Imaging of the Brain
		Principle
		Appropriate Clinical Indications
		Radiopharmaceutical and Dosage
		Patient Prep
		Procedure
	Brain Perfusion SPECT
		Principle
		Indications in Our Clinic
		Radiopharmaceutical and Dosage
		Patient Prep
		Procedure
		Equipment and Setup
	Brain Dopamine Transporter Scan (DaTscan)
		Principle
		Indications
		Radiopharmaceutical and Dosage
		Patient Prep
		Procedure
		Equipment Setup and Image Acquisition
	Cisternogram (CSF Scintigraphy)
		Purpose
		Indications
		Radiopharmaceutical and Dosage
		Patient Preparation/Scheduling
		Procedure
	CSF Leak Scintigraphy With or Without Pledgets
		Purpose
		Indications
		Radiopharmaceutical and Dosage
		Patient Preparation/Scheduling
		Procedure
	Radionuclide Imaging Evaluation of CSF Shunt Patency
		Purposes
		Radiopharmaceutical and Dosage
		Equipment
		Patient Prep
		Procedure
		Image Acquisition
		Image Interpretation
Index




نظرات کاربران